Structure |
Chemical Name |
CAS |
MF |
|
5-[bis-(2-Chloroethyl)amino]-1-methyl-1H-benzimidazole-2-butanoic acid ethyl ester |
87475-54-5 |
C18H25Cl2N3O2 |
|
6-Hydroxykaempferol 3-Rutinoside -6-glucoside |
145134-63-0 |
C33H40O21 |
|
(R)-1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinoline |
85-63-2 |
C21H27NO4 |
|
Linagliptin Impurity P |
|
|
|
Linagliptin Impurity U |
|
|
|
(R)-2-((6-(3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-4-fluorobenzoic acid |
1917324-15-2 |
C18H21FN4O4 |
|
N1,N4-bis((R)-1-(3-(2-cyano-5-fluorobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)piperidin-3-yl)succinamide |
|
C40H42F2N10O6 |
|
ethyl ((1R,3aR,4aR,6S,8aR,9S,9aS)-9-((E)-2-(5-(3-fluorophenyl)pyridin-2-yl)vinyl)-1-methyl-3-oxododecahydronaphtho[2,3-c]furan-6-yl)carbamate |
618385-10-7 |
C29H33FN2O4 |
|
(2R)-2-deoxy-2-fluoro-2-methyl-α/β-D-erythro-pentofuranosyl chloride-3,5-dibenzoate |
1621160-31-3 |
C20H18ClFO5 |
|
Apremilast Impurity F |
|
|
|
Etoricoxib Impurity 17 |
|
|
|
Ibrutinib Impurity 3 |
1226872-27-0 |
C25H26N6O4 |
|
Imatinib Impurity 2 |
1384131-91-2 |
C7H11NO |
|
Mirabegron M5 (YM-538852) |
1365244-63-8 |
C18H22N2O2 |
|
Sofosbuvir Impurity 6 |
|
|
|
Vonoprazan Impurity 2 |
881733-36-4 |
C17H16FN3O2S |
|
Atomoxetine EP impurity A |
56161-70-7 |
C16H19NO |
|
Cinacalcet Impurity 21 |
|
|
|
Dasatinib Impurity D |
|
|
|
Doxofylline Impurity 1 |
1429636-74-7 |
C10H16N4O3 |
|
Isopropyl4-hydroxy-3,5-diisopropylbenzoate |
2095678-97-8 |
C16H24O3 |
|
Sitagliptin EP Impurity B |
1345822-87-8 |
C16H19F5N5O5P |
|
Trospium Impurity |
|
|
|
Vildagliptin Related Compound A |
741657-02-3 |
C17H25N3O |
|
2-amino-9-((1R,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-1,9-dihydro-6H-purin-6-one hydrate |
1367369-78-5 |
C12H15N5O3 |
|
Moxifloxacin Impurity 6 |
849770-49-6 |
C25H29BFN3O8 |
|
Sitafloxacin Impurity A |
500295-83-0 |
C16H16FN3O3 |
|
1-benzylpiperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate |
171723-80-1 |
C25H26N2O2 |
|
Merariveron impurity C |
|
|
|
4H-Inden-4-one, 1-[1,5-dimethyl-5-[(triethylsilyl)oxy]hexyl]octahydro-7a-methyl-, [1R-[1α(R*),3aβ,7aα]]- |
144848-24-8 |
C24H46O2Si |
|
Cefazoline Impurity A |
|
|
|
Rifaximin impurity A |
|
|
|
4,5,6,7-Tetrahydro-thieno[3,2-c]pyridin-2-ol 2-acetate |
1151904-85-6 |
C9H11NO2S |
|
ethyl (R)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylate |
110548-06-6 |
C15H13F2NO4 |
|
methyl (Z)-3-(((4-(2-(4-(2-((4-((((Z)-6-(methoxymethyl)-2-oxoindolin-3-ylidene)(phenyl)methyl)amino)phenyl)(methyl)amino)-2-oxoethyl)piperazin-1-yl)-N-methylacetamido)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate |
2097505-01-4 |
C56H54N8O7 |
|
Roxithromycin EP Impurity J |
134834-12-1 |
C40H73ClN2O14 |
|
Venlafaxine D6 |
940297-06-3 |
C17H27NO2 |
|
Levosimendan Impurity 3 |
|
|
|
Sofosbuvir Impurity29 |
|
|
|
Acarbose Impurity A |
|
|
|
Levosimendan Impurity 1 |
1643439-59-1 |
C22H23N7O2 |
|
Atomoxetine EP Impurity F |
|
|
|
Quetiapine EP Impurity Q |
|
|
|
Cefoxitin Impurity |
|
|
|
Acemetacin Impurity |
|
|
|
ethyl (S)-6,7,8-trifluoro-1-(1-hydroxypropan-2-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylate |
110548-03-3 |
C15H14F3NO4 |
|
ethyl (E)-2-(2-(4-methoxyphenyl)hydrazono)propanoate |
4792-57-8 |
C12H16N2O3 |
|
ACT 373898 |
1433875-14-9 |
C15H17BrN4O5S |
|
Reaxys ID: 3623864 |
129385-61-1 |
C17H10ClNO3 |
|
Olaparib Impurity D |
|
|
|
1-methylpyrrolidin-3-yl 2-(cyclopentyloxy)-2-phenylacetate |
|
C18H25NO3 |
|
Cabozantinib impurity A |
|
|
|
Loratadine Impurity 2 |
|
C22H23ClN2O2 |
|
Metoprolol Impurity 1 |
|
C15H25NO3 |
|
Pitavastatin Impurity 1 |
|
|
|
Trifluridine Impurity 3 |
|
|
|
Vonoprazan Impurity 1 |
|
|
|
Vonoprazan Impurity 4 |
|
|
|
Cinacalcet impurity K |
|
|
|
Valsartan Impurity 13 |
|
C24H29N5O3 |
|
Valsartan Impurity 27 |
|
C24H29N5O3 |
|
Etoricoxib Impurity 6 |
|
|
|
Ezetimibe impurity 3 |
|
|
|
Apremilast Impurity C |
|
|
|
bis(1-benzylpiperidin-3-yl) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate |
166808-97-5 |
C16H16N2O6 |
|
Ticagrelor Imp.J |
2248538-63-6 |
C14H20ClN5O4S |
|
Vortioxetine Imp.E |
508233-77-0 |
C18H22N2S |
|
(3R,4S)-1-(4-fluorophenyl)-3-((S)-3-hydroxy-3-(p-tolyl)propyl)-4-(4-hydroxyphenyl)azetidin-2-one |
1700622-07-6 |
C25H24FNO3 |
|
Topiroxostat Impurity 1 |
|
|
|
Oxcarbazepine Impurity3 |
|
|
|
Mosapride IMP |
|
|
|
4-Ethoxy Paroxetine |
606968-04-1 |
C21H25NO4 |
|
Methylene-Bis Paroxetine |
1292846-10-6 |
C39H40F2N2O6 |
|
Trelagliptin Impurity X |
1938080-44-4 |
C18H22FN5O3 |
|
Afatinib Impurity 19 |
1245555-42-3 |
C21H21ClFN5O2 |
|
Cefoxitin Sodium impurity |
|
|
|
(1S,2S,3S)-Aprepitant |
1242175-40-1 |
C23H21F7N4O3 |
|
2-{[(methoxycarbonylmethyl)(toluene-4-sulfonyl)amino]methyl}-4-phenoxybenzoic acid methyl ester |
1455091-06-1 |
C25H25NO7S |
|
Nicorandil Impurity E |
|
|
|
Prednicarbate Impurity G |
|
|
|
Anastrozole iMpurity F |
|
|
|
Ondansetron IMpurity 6 |
|
|
|
MeropeneM iMpurity 6 |
|
|
|
Macitentan Impurity 33 |
2089065-77-8 |
C28H32Br2N8O6S2 |
|
Cefminox Impurity 5 |
|
|
|
Alogliptin Impurity 20 |
|
|
|
Cyclobenzaprine Impurity 3 |
24167-44-0 |
C15H11BrO |
|
Emtricitabine Impurity 16 |
1160303-44-5 |
C8H10FN3O4S |
|
Etoricoxib Impurity 44 |
|
|
|
Irbesartan Impurity 15 |
|
C25H28N6O |
|
Linagliptin Impurity 54 |
|
|
|
Ornidazole Impurity 13 |
1685275-23-3 |
|
|
Oseltamivir Impurity 44 |
|
|
|
Oseltamivir Impurity 51 |
|
|
|
Palbociclib Impurity 47 |
|
|
|
Rosuvastatin Impurity 98 |
|
|
|
Sildenafil Impurity 38 |
|
C22H30N6O4S |
|
Tenofovir Impurity 70 |
|
|
|
Ticagrelor Impurity 122 |
|
|
|
Tofacitinib Impurity 111 |
2374700-37-3 |
C27H31N5O2S |